Table 3.
Functional comparison of SMAD responsive (from gene expression) and SMAD-target (from ChIP-chip) gene sets obtained using Ingenuity Core analyses
IPA Signaling Pathway | Affymetrix (1095 genes) | SMAD predicted (150 targets) | |||
IPA ratio | IPA p-value | No. molecules | IPA ratio | IPA molecules | |
TGF-beta signaling | 0.169 | 3.68E-06 | 14 | 0.012 | SMAD3 |
RAR activation | 0.08 | 2.50E-03 | 15 | 0.011 | GTF2H2, SMAD3 |
IGF-1 signaling | 0.108 | 3.58E-03 | 10 | n/a | n/a |
Wnt/beta-catenin signaling | 0.084 | 4.12E-03 | 14 | 0.018 | CSNK1A1, DKK1, FRAT1 |
Cell cycle: G1/S checkpoint regulation | 0.117 | 7.37E-03 | 7 | 0.033 | HDAC9, SMAD3 |
BMP signaling | 0.097 | 1.01E-02 | 10 | n/a | n/a |
GM-CSF signaling | 0.113 | 1.34E-02 | 7 | 0.016 | CAMK2D |
LPS/IL-1 mediated inhibition of RXR function | 0.065 | 2.68E-02 | 13 | n/a | n/a |
IL-4 signaling | 0.1 | 5.15E-02 | 7 | 0.014 | NFAT5 |
Only significant signaling pathways are listed. Ratio shows the relative overlap between number of molecules per pathway within each dataset over the total number of pathway-specific molecules present in Ingenuity Knowledge Base.